Remarks at Conference on Directions in Health Economics Regarding Research on Health Insurance and Biomedical Research and Development.
Purchase Print Copy
| Format | List Price | Price | |
|---|---|---|---|
| Add to Cart | Paperback6 pages | $20.00 | $16.00 20% Web Discount |
Comments on significant research opportunities for economists: (1) Why does health insurance cover minor costs better than major ones--why comparatively low upper limits? (2) What is the effect of methods of reimbursing providers of medical care? (3) Market structure problems. (4) Difficulties in measuring elasticity of demand. (5) Understanding health stock loss. (6) Effects of price schedules. (7) Marginal prices. Turning to R&D, development is defined as improving a product along existing quantifiable dimensions, and research as introducing new products (new dimensions). (8) Has reimbursement insurance reduced development in cost reduction? (9) What is the tradeoff between expenditure and speed of development? (10) What is optimal patent policy? (11) Optimal size and distribution of research firms and researchers? (12) Incentives for efficiency? (13) Optimal length of support--what is the tradeoff between the greater responsiveness and control obtained with shorter periods, vs. greater insecurity and nonproductive times writing proposals? 6 pp. Ref.
This report is part of the RAND Corporation Paper series. The paper was a product of the RAND Corporation from 1948 to 2003 that captured speeches, memorials, and derivative research, usually prepared on authors' own time and meant to be the scholarly or scientific contribution of individual authors to their professional fields. Papers were less formal than reports and did not require rigorous peer review.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.